BACKGROUND. Attacks of cluster headache are difficult to treat. Sumatriptan, an agonist of 5-hydroxytryptamine1-like receptors, has proved effective in the treatment of migraine. The clinical similarities between migraine and cluster headache and positive results from an open pilot study in patients with cluster headache indicated that sumatriptan should be evaluated more rigorously in the treatment of this condition. METHODS. We conducted a randomized, double-blind, placebo-controlled crossover study to assess the efficacy and tolerability of sumatriptan in 49 patients with cluster headache. The patients received, in random order, a subcutaneous injection of 6 mg of sumatriptan for one cluster-headache attack and placebo for another attack. The results for the two attacks could be fully evaluated for 39 patients. A response to treatment was defined as complete or almost complete relief of headache (no pain or mild pain) within 15 minutes after the injection. RESULTS. In the 39 patients, the severity of headache decreased in 74 percent of the attacks within 15 minutes of treatment with sumatriptan, as compared with 26 percent of the attacks for which placebo was given (P less than 0.001). Thirty-six percent of the patients were free of pain within 10 minutes after the administration of sumatriptan, as compared with 3 percent after placebo (P less than 0.001); by 15 minutes these numbers had increased to 46 percent and 10 percent, respectively (P less than 0.001). Thirteen percent of the patients required oxygen as an additional treatment 15 minutes after receiving sumatriptan, as compared with 49 percent of those who received placebo. The severity of functional disability and the incidence of ipsilateral conjunctival injection also decreased more in response to sumatriptan than placebo. Sumatriptan was well tolerated, and there were no serious adverse events. CONCLUSIONS. Sumatriptan is an effective and well-tolerated treatment for acute attacks of cluster headache.
This article has been cited by other articles:
Baskar, S., Etti, R., Kitas, G., Klocke, R.
(2008). Cluster headache or giant cell arteritis?. BMJ Case Reports
2008: bcr0720080444-bcr0720080444
[Abstract][Full Text]
Rapoport, A. M., Mathew, N. T., Silberstein, S. D., Dodick, D., Tepper, S. J., Sheftell, F. D., Bigal, M. E.
(2007). Zolmitriptan nasal spray in the acute treatment of cluster headache: A double-blind study. Neurology
69: 821-826
[Abstract][Full Text]
Cittadini, E., May, A., Straube, A., Evers, S., Bussone, G., Goadsby, P. J.
(2006). Effectiveness of Intranasal Zolmitriptan in Acute Cluster Headache: A Randomized, Placebo-Controlled, Double-blind Crossover Study. Arch Neurol
63: 1537-1542
[Abstract][Full Text]
Paemeleire, K., Bahra, A., Evers, S., Matharu, M. S., Goadsby, P. J.
(2006). Medication-overuse headache in patients with cluster headache.. Neurology
67: 109-113
[Abstract][Full Text]
Matharu, M S, van Vliet, J A, Ferrari, M D, Goadsby, P J
(2005). Verapamil induced gingival enlargement in cluster headache. J. Neurol. Neurosurg. Psychiatry
76: 124-127
[Abstract][Full Text]
van Vliet, J. A., Bahra, A., Martin, V., Ramadan, N., Aurora, S. K., Mathew, N. T., Ferrari, M. D., Goadsby, P. J.
(2003). Intranasal sumatriptan in cluster headache: Randomized placebo-controlled double-blind study. Neurology
60: 630-633
[Abstract][Full Text]
Matharu, M. S, Goadsby, P. J
(2002). TRIGEMINAL AUTONOMIC CEPHALGIAS. J. Neurol. Neurosurg. Psychiatry
72: ii19-26
[Full Text]
Matharu, M. S., Goadsby, P. J.
(2002). Persistence of attacks of cluster headache after trigeminal nerve root section. Brain
125: 976-984
[Abstract][Full Text]
Bahra, A., May, A., Goadsby, P. J.
(2002). Cluster headache: A prospective clinical study with diagnostic implications. Neurology
58: 354-361
[Abstract][Full Text]
Goadsby, P. J., Lipton, R. B., Ferrari, M. D.
(2002). Migraine -- Current Understanding and Treatment. NEJM
346: 257-270
[Full Text]
May, A., Bahra, A., Buchel, C., Frackowiak, R. S. J., Goadsby, P. J.
(2000). PET and MRA findings in cluster headache and MRA in experimental pain. Neurology
55: 1328-1335
[Abstract][Full Text]
Bahra, A., Gawel, M. J., Hardebo, J.-E., Millson, D., Breen, S. A., Goadsby, P. J.
(2000). Oral zolmitriptan is effective in the acute treatment of cluster headache. Neurology
54: 1832-1839
[Abstract][Full Text]
Dahlof, C., Ekbom, K., Persson, L.
(1994). Clinical Experiences From Sweden on the Use of Subcutaneously Administered Sumatriptan in Migraine and Cluster Headache. Arch Neurol
51: 1256-1261
[Abstract]
(1991). SUMATRIPTAN RELIEVES BOTH MIGRAINE AND CLUSTER HEADACHES. JWatch General
1991: 3-3
[Full Text]
Previous
